Knee replacement Market Share

Knee Replacement Market Overview

Knee Replacement Market Size was valued at USD 9.71 Billion in 2023. The Global Knee Replacement industry is projected to grow from USD 10.98 Billion in 2024 to USD 27.19 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.59% during the forecast period (2024 - 2032).

 Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

High incidence of road accidents leading to amputations, and increasing prevalence of osteoarthritis & rise in the number of Knee Injury Cases are the key market drivers enhancing the market growth.

KEM Hospital in Mumbai made a large step forward in medicine when they integrated a robotic arm into their knee replacement treatments in February 2024. Through this, the hospital became one of the first public hospitals in India to perform such an operation. Corporate sponsorship facilitated this step. Furthermore, the hospital’s commitment to affordable health care was evident when it performed the first 300 procedures for free.

Stryker had made Menix a legally binding offer to acquire SERF SAS, a France-based company specialized in joint replacements.

In October 2023, DePuy Synthes (US) launched the VELYS Robotic-Assisted Solution with performance optimization as well as impact delivery on patients’ outcomes through insightful analytics, flexible deployment and proven results.

Malaysia Healthcare unveiled the MH Wellness Fair (the Malaysia HealthcareWellness Fair) in October 2023. These internationally accredited hospitals provide all-inclusive healthcare packages and services, including total knee replacement treatment.

For instance, OrthAlign launched Lantern recently, a handheld smart tool for knee replacement surgery by private United States Company, which is OrthAlign, in November 2021. Such continuous product launches are anticipated to drive market growth in the country; thus, increasing demand of these products has been witnessed.

In August 2021, Zimmer Biomet Holdings, Inc., and Canary Medical were given a U.S. Food and Drug Administration (FDA) De Novo classification grant together with approval to market tibial extension for Persona IQ-the world’s only smart knee cleared by FDA for total knee replacement surgery.

In June 2021, Think Surgical Inc. and Ortho Development Corporation announced that Ortho Development's Balanced Knee System and TriMax implants have been cleared by the FDA as part of Think Surgical's TSolution One Total Knee Application.

Knee Replacement Market Trends

• Rising Prevalence of Knee Osteoarthritis to boost market growth

The rising prevalence of knee osteoarthritis is one of the key factors driving the market growth of the knee replacement. Knee osteoarthritis is a common condition, particularly among the elderly population, which causes the degradation of cartilage in the knee joint, leading to pain and mobility issues. As the population ages, the prevalence of knee osteoarthritis is expected to increase, driving demand for knee replacement surgery. Knee replacement surgery involves replacing the damaged knee joint with a prosthetic implant. The procedure is typically recommended for patients with severe knee osteoarthritis who have not responded to conservative treatments such as medication and physical therapy. The increasing prevalence of knee osteoarthritis means that there is a growing pool of potential candidates for knee replacement surgery. This, in turn, is expected to drive the demand for knee replacement implants and related products, supporting the market growth of the knee replacement. For instance, according to The Centers for Disease Control and Prevention (CDC) reports that in 2019, an estimated 32.5 million adults in the United States had osteoarthritis, and knee osteoarthritis is one of the most common types. Also, In the United Kingdom, the National Joint Registry (NJR) reports that 106,381 knee replacement procedures were performed in the 2019/20 financial year. Knee osteoarthritis is one of the primary reasons for knee replacement surgery.

Also, during the forecast period, it is anticipated that the frequency of post-traumatic arthritis will rise along with the demand for minimally invasive surgical methods. For instance, the Agency for Healthcare Research and Quality (AHRQ) estimates that more than 600,000 knee replacement procedures are carried out in the United States each year. Furthermore, in August 2021, the FDA authorized Persona IQ, the first smart knee replacement device in the world, for use in total knee replacement surgery. Persona IQ was developed by Canary Medical, a medical data company, and Zimmer Biomet, a pioneer in global medical technology. The market growth is driven by the leading companies' patient-centric development approach, which takes into account the unmet demands for a potent treatment of severe knee osteoarthritis.

The market for knee replacement devices has grown significantly over the years as a result of improvements in surgical methods including robotic surgery and navigation support systems. Also, the rising demand for affordable, personalized knee implants motivates large manufacturers to spend money on research and development, which opens up new opportunities for growth. The global market for knee replacement devices is growing due to increased awareness of the need to treat orthopedic problems. 

Knee replacement surgery, or knee arthroplasty, involves removing the diseased knee tissues and replacing them with an artificial joint or implant. Patients with rheumatoid arthritis, osteoarthritis, or post-traumatic arthritis are treated with this kind of surgery. The materials that make up the implant used during surgical procedures include metal alloys, ceramics, and plastic. The main purposes of knee replacement are to resurface the knee joint's damaged areas and ease patients' persistent knee discomfort. The diseased cartilage and tissues from the knee joint are removed during a knee arthroplasty procedure and replaced with an artificial knee implant.

With a sharp rise in the prevalence of osteoarthritis and other knee illnesses, including rheumatoid arthritis and psoriatic arthritis worldwide, the demand for this technique is projected to increase significantly in the future years. Another key element in improving procedures is the younger population, which has a high body mass index. The market will likely grow during the forecast period due to rising healthcare costs and technical advancements in knee replacement surgery. The frequency of osteoarthritis and other joint illnesses, such as psoriatic arthritis and rheumatoid arthritis, is increasing worldwide, a major factor driving the expansion of the knee replacement devices sector. Implants made of precious metals using cutting-edge technologies are used during knee replacement surgeries. Furthermore, the strict restrictions for product approval increase the cost of these products. Developing nations with little healthcare spending and a shortage of qualified surgeons have seen limited access to these items.

Additionally, during the forecast period, it is anticipated that the frequency of post-traumatic arthritis and the increasing need for minimally invasive surgical methods will rise. Studies have shown that the employment of cutting-edge technologies, such as artificial intelligence, AI, and robotics, increases the efficiency of surgical procedures. These technologically advanced medical instruments are in higher demand than ever. With the aid of AI, surgeons may create highly customized surgical plans that consider each patient's unique knee motion. The expanding obesity pandemic and the rapidly aging population are projected to increase requests for knee replacement surgery in the coming years.

Knee Replacement Market Segment Insights

Knee Replacement End Use Insights

The Market segments of Knee Replacement, based on fusion End Use, includes Clinics and Hospitals, Rehabilitation Centres, Specialty Centres. The hospitals segment held the majority share in 2022 contribution to around ~65-70% in respect to the Knee Replacement Market revenue. This is mostly because hospitals now have cutting-edge facilities and a growing healthcare infrastructure. In the upcoming years, it is expected that the healthcare sector would maintain its dominance. This is due to the increase in orthopedic procedures conducted in hospitals and the growth in patients seeking treatment for orthopedic injuries.

In 2021: North Shore University Hospital, part of Northwell Health in New York, launched a Comprehensive Joint Replacement Program, which includes knee replacement surgery using robotic technology.

In 2020: Beaumont Health in Michigan launched a Joint Replacement Home Recovery Program, which allows knee replacement patients to recover at home with remote monitoring from healthcare professionals.

Knee Replacement Product Insights

The Knee Replacement Market segmentation, based on Product, includes partial knee reconstructive implants, total knee reconstructive implants, medical pivot implants, fixed bearing implants, revision knee reconstructive implants, mobile bearing implants, others. The total knee reconstructive implants segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2024-2032. This is due to increased demand for implants and customized replacement systems. The considerable patient base of arthritis sufferers and the rise in the number of patients receiving the operation are further reasons that contribute to the segment's high proportion of the market.

In 2021: Zimmer Biomet launched the Persona IQ, a personalized knee implant system that uses data from MRIs and X-rays to create customized implants for individual patients. At Brisbane's Mater Hospital, patients who have had knee replacement surgery are subjected to non-invasive pain assessment by Queensland researchers using innovative light treatment patches. To aid patients in recovering more quickly and painlessly, 60 patients from Mater Hospital Brisbane are taking part in a research study into the effects of photobiomodulation therapy on post-operative pain and functional recovery. A randomized experiment is being conducted to evaluate the effectiveness of the light-emitting adhesive patch that shines blue and red light on the joint connecting the knee and the thigh muscle. The device under inquiry uses a unique, 3-D printed self-adhesive patch comprising thousands of micro-diodes that emit light frequencies discovered in earlier research.

Figure 2: Knee Replacement Market, by Surgery, 2022 & 2032 (USD Bllion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Knee Replacement Regional Insights

By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Knee Replacement market accounted for USD 2.97 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the rising elderly population, increasing prevalence of arthritis, and other joint abnormalities. Additionally, it is projected that the availability of a well-established healthcare facility and access to technically advanced implant surgeries will drive market expansion.

Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: Knee Replacement Market Share By Region 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe knee replacement market accounts for the second-largest market share due to the availability of cutting-edge treatment facilities, government backing for the growth of the healthcare industry, an ageing population, and growing road accidental cases. Further, the Germany market of knee replacement held the largest market share, and the UK market of knee replacement was the fastest growing market in the European region

The Asia-Pacific Knee Replacement Market is expected to grow at the fastest CAGR from 2024 to 2032. This is due to untapped development potential, increasing use of orthopaedic implants, rising rates of arthritis, and quickly developing healthcare infrastructure. Moreover, rising consumer awareness of healthcare issues and technology developments in developing nations are anticipated to support expansion. Moreover, China market of knee replacement held the largest market share, and the India market of knee replacement was the fastest growing market in the Asia-Pacific region

Knee Replacement Key Market Players & Competitive Insights

Major market players are spending a lot of money on R&D to increase their product lines, which will help the market of knee replacement grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the knee replacement industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the global knee replacement industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, knee replacement industry has provided treatment with some of the most significant benefits. The knee replacement market major player such as Zimmer Inc. (US), DePuy Synthes (US), Smith and Nephew (UK) and others are working to expand the market demand by investing in research and development activities.

Zimmer Inc. is a medical technology company that specializes in orthopedic implants and related surgical products. The company was founded in 1927 and is headquartered in Warsaw, Indiana, USA. Zimmer Inc. is a subsidiary of Zimmer Biomet, which was formed in 2015 through the merger of Zimmer Holdings and Biomet. The company's product portfolio includes implants for joint replacement surgeries, such as hip, knee, and shoulder replacements, as well as products for sports medicine, spine, and dental procedures. Some of the company's notable products include the Persona line of knee implants, the G7 Acetabular System for hip replacements, and the Comprehensive Reverse Shoulder System for shoulder replacement. In 2021, Zimmer Biomet launched the Persona IQ, a personalized knee implant system that uses data from MRIs and X-rays to create customized implants for individual patients.

Also, Smith+Nephew is a global medical technology company headquartered in London, UK. The company specializes in developing and selling medical devices, particularly in the areas of orthopedics, sports medicine, and wound management. Smith+Nephew's product portfolio includes devices for joint replacement surgeries, such as hip and knee replacements, as well as devices for sports medicine procedures, such as ligament repair and meniscus repair. The company also offers a range of advanced wound care products, including dressings, negative pressure wound therapy systems, and devices for managing chronic wounds. In 2020, Smith+Nephew introduced the OR3O Dual Mobility System, a total knee implant designed to reduce the risk of dislocation and improve stability.

Key Companies in the market of knee replacement includes

• Zimmer Inc. (US)


• Stryker (US)


• Smith and Nephew (UK)


• Exactech, Inc. (US)


• Corin Group (UK)


• DePuy Synthes (US)


• Aesculap Implants Systems LLC (US)


• Medacta International. (Switzerland)


• Allegra Orthopaedics Limited (Australia)


• Kinamed, Inc. (US), among others

Knee Replacement Industry Developments

October 2023: DePuy Synthes (US) launched the VELYS Robotic-Assisted Solution. The VELYS Robotic-Assisted Solution offers insightful analysis, flexible implementation, and validated performance intended to maximize patient outcomes and deliver efficiency. 

The Medacta Group S.A.(Switzerland) has launched the GMK SpheriKA Knee Implant. The GMK Sphere is a novel total knee replacement system that aims to reduce post-operative knee discomfort and increase TKA patient satisfaction during daily living activities by providing optimal functional stability.

March 2023: Stryker (UK) introduces the surgical robotics platform Mako Total Knee 2.0. Stryker introduces the surgical robotics platform Mako Total Knee 2.0. The Mako system assists in keeping surgeons inside predetermined bounds and directs them as necessary. This facilitates more precise implant positioning and alignment for patients. 

November 2022: The US FDA has approved Zimmer Biomet's Persona OsseoTi Keel Tibia for Cementless Knee Replacement. The newest component of the clinically proven Persona Knee System, Persona OsseoTi, features Zimmer Biomet's OsseoTi Porous Metal Technology, which creates a structure that closely mimics the architecture of human cancellous, or spongey, bone by combining 3D printing technology with anatomical data.

September 2022: Smith+Nephew (UK) has launched OR3O Dual Mobility System in Japan. Its OR3O Dual Mobility System is currently accessible in Japan for primary and revision hip arthroplasty surgeries.

The US FDA has approved Zimmer Biomet's ROSA Partial Knee System, which enables robotically assisted partial knee replacement.

Stryker (UK) acquired OrthoSensor (US), a maker of digital knee replacements, to advance the use of big data and digital technology in total joint replacement a result of this acquisition, OrthoSensor aims to provide surgeons additional knowledge so they can balance the soft tissue in the knee to achieve a more balanced walk.

Knee Replacement Market Segmentation

Knee Replacement End Use Outlook

• Clinics and Hospitals


• Rehabilitation Centres


• Specialty Centres

Knee Replacement Product Outlook

• Partial Knee Reconstructive Implants


• Total Knee Reconstructive Implants


• Medical Pivot Implants


• Fixed Bearing Implants


• Revision Knee Reconstructive Implants


• Mobile Bearing Implants


• Others

Knee Replacement Materials Outlook

• Metal Alloy


• Ceramic Material


• Strong Plastic Parts

Knee Replacement Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America